Differences in the Effects of d- and dl-Sotalol on Isolated Human Ventricular Muscle: Electromechanical Activity After Beta-Adrenoceptor Stimulation
- PMID: 10684401
- DOI: 10.1177/107424849600100110
Differences in the Effects of d- and dl-Sotalol on Isolated Human Ventricular Muscle: Electromechanical Activity After Beta-Adrenoceptor Stimulation
Abstract
BACKGROUND: The racemate of sotalol (dl-sotalol) and its dextrorotatory isomer (d-sotalol) are equally effective in increasing isolated cardiac action potential durations. dl-Sotalol, however, is reported to be more effective than d-sotalol in increasing ventricular effective refractoriness following coronary artery occlusion. These differences are attributed to the beta-adrenergic blocking properties of dl-sotalol. We wished to determine if in isolated human ventricular muscle preparations the effects of 30 µM d0 and dl-sotalol could be modified by preexposure to 1 µM isoproterenol. METHODS AND RESULTS: Microelectrodes were used to record action potential duration (APD) in the presence and absence of isoproterenol during continuous pacing. Preparations were obtained from explanted hears of transplant recipients suffering idiopathic cardiomyopathies. Without isoproterenol, APD measured at 90% of repolarization (APD(90)) was significantly increased by both d- and dl-sotalol (352.0 +/- 17.7 to 418.0 +/- 23.8 ms, P <.05; and 339.2 +/- 17.0 to 405.0 +/- 25.3 ms, P <.05; respectively). Isoproterenol alone, prior to sotalol exposure, tended to shorten APD(90) in the two groups first exposed to this beta-adenoceptor agonist and subsequently exposed to either d-sotalol or dl-sotalol (317.5 +/- 16.5 to 286.3 +/- 28.8 ms and 288.0 +/- 16.2 to 254.0 +/- 15.0 ms, respectively). dl-Sotalol significantly increased APD(90) from its baseline value after isoproterenol (288.0 +/- 16.2 to 359.0 +/- 25.1 ms, P <.005) while d-sotalol did not (317.5 +/- 16.5 to 316.2 +/- 28.5 ms, NS). CONCLUSIONS: The beta-adrenergic blocking properties of dl-sotalol may be important in determining antiarrhythmic efficacy when tonic sympathetic nervous activity is high.
Similar articles
-
Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol.Circulation. 1995 Jan 15;91(2):262-4. doi: 10.1161/01.cir.91.2.262. Circulation. 1995. PMID: 7805226
-
Comparative antifibrillatory effects of d- and dl-sotalol in normal and ischaemic ventricular muscle of the cat.J Cardiovasc Pharmacol. 1990 Feb;15(2):233-8. doi: 10.1097/00005344-199002000-00009. J Cardiovasc Pharmacol. 1990. PMID: 1689418
-
Pro- and antiarrhythmic effects of d-sotalol and dl-sotalol in an isolated tissue model of ischemia and reperfusion.J Pharmacol Exp Ther. 1994 Oct;271(1):184-92. J Pharmacol Exp Ther. 1994. PMID: 7965713
-
Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.Circulation. 2005 Sep 6;112(10):1392-9. doi: 10.1161/CIRCULATIONAHA.105.550111. Epub 2005 Aug 29. Circulation. 2005. PMID: 16129791
-
Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.J Pharmacol Exp Ther. 1998 May;285(2):687-94. J Pharmacol Exp Ther. 1998. PMID: 9580614
Cited by
-
Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes.Front Cardiovasc Med. 2022 Aug 12;9:966094. doi: 10.3389/fcvm.2022.966094. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36035948 Free PMC article. Review.
-
IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes.Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1611-21. doi: 10.1152/ajpheart.00481.2015. Epub 2016 Apr 8. Am J Physiol Heart Circ Physiol. 2016. PMID: 27059077 Free PMC article.
LinkOut - more resources
Full Text Sources
Miscellaneous
